Next Article in Journal
Physiologically Based Pharmacokinetic Model of CYP2D6 Associated Interaction Between Venlafaxine and Strong Inhibitor Bupropion—The Influence of Age-Relevant Changes and Inhibitory Dose to Classify Therapeutical Success and Harm
Previous Article in Journal
Advanced Nanopharmaceutical Intervention for the Reduction of Inflammatory Responses and the Enhancement of Behavioral Outcomes in APP/PS1 Transgenic Mouse Models
 
 
Review

Article Versions Notes

Pharmaceutics 2025, 17(2), 178; https://doi.org/10.3390/pharmaceutics17020178
Action Date Notes Link
article xml file uploaded 31 January 2025 14:28 CET Original file -
article xml uploaded. 31 January 2025 14:28 CET Update https://www.mdpi.com/1999-4923/17/2/178/xml
article pdf uploaded. 31 January 2025 14:28 CET Version of Record https://www.mdpi.com/1999-4923/17/2/178/pdf
article html file updated 31 January 2025 14:29 CET Original file https://www.mdpi.com/1999-4923/17/2/178/html
Back to TopTop